FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083729315> ?p ?o ?g. }

• W2083729315 endingPage "F368" @default.
• W2083729315 startingPage "F359" @default.
• W2083729315 abstract "Tubulointerstitial inflammation and fibrosis are hallmarks of chronic progressive renal diseases. To characterize the functional interaction between cell infiltration and matrix expansion, this study compared the immunosuppressant mycophenolate mofetil (MMF), intended as primarily anti-inflammatory intervention, the angiotensin-converting enzyme inhibitor enalapril, intended as primarily an anti-fibrotic drug, and a combination of both as anticipated anti-inflammatory/anti-fibrotic intervention. The model used was anti-thy1-induced chronic-progressive glomerulosclerosis (cGS) in the rat, where a brief anti-thy1-induced glomerular injury progresses spontaneously toward tubulointerstitial fibrosis and renal insufficiency. cGS was induced by injection of anti-thy1 antibody into uninephrectomized Wistar rats. One week after disease induction, animals were randomly assigned to the following groups: cGS, cGS plus MMF (20 mg·kg body wt −1 ·day −1 ), cGS plus high-dose enalapril (12 mg·kg body wt −1 ·day −1 ), and cGS plus both. At week 16 after disease induction, MMF or enalapril alone reduced signs of chronic renal disease significantly and similarly compared with the untreated cGS group. Variables measured included proteinuria, blood pressure, tubulointerstitial and glomerular matrix accumulation, expression of transforming growth factor-β 1 , fibronectin, and plasminogen activator inhibitor-1, infiltration of lymphocytes and macrophages, plasma creatinine and urea levels, and glomerular filtration rate. Combined MMF and enalapril treatment was not superior to single therapy. In conclusion, MMF slows the progression of chronic renal fibrosis and renal insufficiency as effectively as high-dose enalapril in the anti-thy1-induced chronic-progressive glomerulosclerosis model. The dual anti-inflammatory/anti-fibrotic intervention does not yield additive renoprotective effects, indicating that MMF and enalapril interfere with similar or very closely related pathways involved in progression of renal disease." @default.
• W2083729315 created "2016-06-24" @default.
• W2083729315 creator A5015739507 @default.
• W2083729315 creator A5019114817 @default.
• W2083729315 creator A5021038666 @default.
• W2083729315 creator A5021215173 @default.
• W2083729315 creator A5034864437 @default.
• W2083729315 creator A5036932318 @default.
• W2083729315 creator A5056678212 @default.
• W2083729315 creator A5057301328 @default.
• W2083729315 creator A5089061569 @default.
• W2083729315 creator A5090803435 @default.
• W2083729315 date "2005-08-01" @default.
• W2083729315 modified "2023-09-27" @default.
• W2083729315 title "Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril" @default.
• W2083729315 cites W1966134006 @default.
• W2083729315 cites W1974587800 @default.
• W2083729315 cites W1976335282 @default.
• W2083729315 cites W1979126902 @default.
• W2083729315 cites W1993718800 @default.
• W2083729315 cites W1999093674 @default.
• W2083729315 cites W2000084615 @default.
• W2083729315 cites W2017096535 @default.
• W2083729315 cites W2037500902 @default.
• W2083729315 cites W2045389856 @default.
• W2083729315 cites W2045967295 @default.
• W2083729315 cites W2047494883 @default.
• W2083729315 cites W2053338918 @default.
• W2083729315 cites W2059988766 @default.
• W2083729315 cites W2060335268 @default.
• W2083729315 cites W2060705706 @default.
• W2083729315 cites W2066051767 @default.
• W2083729315 cites W2066538838 @default.
• W2083729315 cites W2081765204 @default.
• W2083729315 cites W2108244474 @default.
• W2083729315 cites W2123627837 @default.
• W2083729315 cites W2124579702 @default.
• W2083729315 cites W2128520582 @default.
• W2083729315 cites W2133357709 @default.
• W2083729315 cites W2151248872 @default.
• W2083729315 cites W2156632978 @default.
• W2083729315 cites W2165325650 @default.
• W2083729315 cites W2324505043 @default.
• W2083729315 cites W2335187016 @default.
• W2083729315 cites W2408961004 @default.
• W2083729315 cites W2409666630 @default.
• W2083729315 cites W3021250193 @default.
• W2083729315 cites W3030237074 @default.
• W2083729315 doi "https://doi.org/10.1152/ajprenal.00442.2004" @default.
• W2083729315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15769934" @default.
• W2083729315 hasPublicationYear "2005" @default.
• W2083729315 type Work @default.
• W2083729315 sameAs 2083729315 @default.
• W2083729315 citedByCount "38" @default.
• W2083729315 countsByYear W20837293152012 @default.
• W2083729315 countsByYear W20837293152013 @default.
• W2083729315 countsByYear W20837293152014 @default.
• W2083729315 countsByYear W20837293152016 @default.
• W2083729315 countsByYear W20837293152017 @default.
• W2083729315 countsByYear W20837293152022 @default.
• W2083729315 crossrefType "journal-article" @default.
• W2083729315 hasAuthorship W2083729315A5015739507 @default.
• W2083729315 hasAuthorship W2083729315A5019114817 @default.
• W2083729315 hasAuthorship W2083729315A5021038666 @default.
• W2083729315 hasAuthorship W2083729315A5021215173 @default.
• W2083729315 hasAuthorship W2083729315A5034864437 @default.
• W2083729315 hasAuthorship W2083729315A5036932318 @default.
• W2083729315 hasAuthorship W2083729315A5056678212 @default.
• W2083729315 hasAuthorship W2083729315A5057301328 @default.
• W2083729315 hasAuthorship W2083729315A5089061569 @default.
• W2083729315 hasAuthorship W2083729315A5090803435 @default.
• W2083729315 hasConcept C126322002 @default.
• W2083729315 hasConcept C126894567 @default.
• W2083729315 hasConcept C134018914 @default.
• W2083729315 hasConcept C159641895 @default.
• W2083729315 hasConcept C27016395 @default.
• W2083729315 hasConcept C2775940317 @default.
• W2083729315 hasConcept C2777390665 @default.
• W2083729315 hasConcept C2777880890 @default.
• W2083729315 hasConcept C2778176769 @default.
• W2083729315 hasConcept C2778653478 @default.
• W2083729315 hasConcept C2779561371 @default.
• W2083729315 hasConcept C2779611605 @default.
• W2083729315 hasConcept C2780091579 @default.
• W2083729315 hasConcept C2780306776 @default.
• W2083729315 hasConcept C2780559512 @default.
• W2083729315 hasConcept C71924100 @default.
• W2083729315 hasConcept C84393581 @default.
• W2083729315 hasConceptScore W2083729315C126322002 @default.
• W2083729315 hasConceptScore W2083729315C126894567 @default.
• W2083729315 hasConceptScore W2083729315C134018914 @default.
• W2083729315 hasConceptScore W2083729315C159641895 @default.
• W2083729315 hasConceptScore W2083729315C27016395 @default.
• W2083729315 hasConceptScore W2083729315C2775940317 @default.
• W2083729315 hasConceptScore W2083729315C2777390665 @default.
• W2083729315 hasConceptScore W2083729315C2777880890 @default.
• W2083729315 hasConceptScore W2083729315C2778176769 @default.
• W2083729315 hasConceptScore W2083729315C2778653478 @default.

• next